Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FSMF3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,598
Award facts
- Contract value 100% obligated
- $20,598.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,598.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of January 28, 2026. DMS Pharmaceutical Group will perform the work from its Park Ridge facility and will serve as the prime contractor with no identified subcontractors on this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support the Department of Defense military healthcare operations globally. DMS Pharmaceutical Group's demonstrated capability across a diverse product portfolio—including specialty biologics, immunosuppressants, oncology treatments, and routine pharmaceuticals—positions the company as a critical supplier within the federal pharmaceutical supply chain serving DoD healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FSMF3?
SPE2DR26FSMF3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FSMF3 worth?
The government has obligated $20,598 on SPE2DR26FSMF3.
Is contract SPE2DR26FSMF3 an order under another contract?
Yes. SPE2DR26FSMF3 is a delivery order under SPE2DR25D9320, an indefinite delivery contract.
Was contract SPE2DR26FSMF3 competed?
The extent of competition for SPE2DR26FSMF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award